Ignite Creation Date:
2024-05-06 @ 4:01 PM
Last Modification Date:
2024-10-26 @ 2:02 PM
Study NCT ID:
NCT04844164
Status:
COMPLETED
Last Update Posted:
2022-08-11
First Post:
2021-04-09
Brief Title:
Vitamin D Metabolism in Patients With Endocrine Disorders
Sponsor:
Endocrinology Research Centre Moscow
Organization:
Endocrinology Research Centre Moscow
Study Overview
Official Title:
Prospective Non-randomised Controlled Study of Vitamin D Metabolism in Patients With Endocrine Disorders Acromegaly Cushings Disease Primary Hyperparathyroidism Diabetes Mellitus Type 1 Treated With Cholecalciferol Bolus Dose
Status:
COMPLETED
Status Verified Date:
2022-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This prospective controlled interventional study aims to reveal the diversity of vitamin D metabolism in patients with certain endocrine disorders Cushings disease acromegaly primary hyperparathyroidism diabetes mellitus type 1 compared to healthy adults All patients will receive a single dose 150000 IU of cholecalciferol aqueous solution orally Laboratory assessments including serum vitamin D metabolites 25OHD3 25OHD2 125OH2D3 3-epi-25OHD3 2425OH2D3 and D3 free 25OHD vitamin D-binding protein DBP and parathyroid hormone PTH as well as serum and urine biochemical parameters will be performed before the intake and on Days 1 3 and 7 after the administration
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 19-15-00243 | OTHER_GRANT | Russian Science Foundation | None |